Overview

Efficacy of Vortioxetine Versus Escitalopram on Cognitive Function in Patients With Inadequate Response to Current Antidepressant Treatment of Major Depressive Disorder

Status:
Completed

Trial end date:
2016-03-01

Target enrollment:

Participant gender:

Summary

This study aims at evaluating the effect of vortioxetine on cognitive dysfunction in major depressive disorder (MDD) patients with inadequate response to current antidepressant treatment.

Phase:

Phase 3

Details

Lead Sponsor:

H. Lundbeck A/S

Treatments:

Antidepressive Agents
Citalopram
Dexetimide
Vortioxetine